Dr. Nihar Kiritkumar Patel, MD

Dr. Patel practices at Texas Oncology-Round Rock in Round Rock, Texas.

Dr. Patel's NPI, 1528228921, was assigned on June 10, 2008. Dr. Patel graduated from LSU Health Shreveport School of Medicine in 2007. Dr. Patel's Texas license number on file is Q5531.

Dr. Patel's primary practice is Texas Oncology-Round Rock, at 2410 Round Rock Ave Suite 150, Round Rock, TX 78681. The practice phone is (512) 539-6681.

Dr. Patel's primary practice is Texas Oncology-Round Rock in Round Rock, Texas. Dr. Patel is also affiliated with St. David's Round Rock Medical Center. The medical group on file is Texas Oncology. Dmand AI also links Dr. Patel to 1 more hospital and 1 group practice or clinic, each named with a free account. Dr. Patel's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Patel is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Patel's licenses on file in 3 states: Texas, Louisiana and District of Columbia.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Patel treats.

CMS data shows 107,862 Medicare services from Dr. Patel across 66 procedure codes in 2024, for 610 Medicare patients. Medicare paid $1,333,903 for them.

CMS counts 610 Medicare patients who saw Dr. Patel in 2024. The largest group is 65 to 74, with 271 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 65, with 57% women.

In 2024, Dr. Patel wrote 795 Medicare Part D claims for 164 patients. 74% of them were for generic drugs. CMS names the drug for 476 of them, across 15 drugs with 11 or more claims each, at $618,839 in total drug cost. In 2023, CMS named 381 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Patel for performance year 2024, reported through an alternative payment model (APM). Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Patel as offering telehealth.

Dmand AI links 11 papers to Dr. Patel, published from 2013 to 2016. 2013 was the busiest year, with 5. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Hematologic Diseases and Remission Induction. Dr. Patel has published most often in Clin Med Insights Oncol. Dr. Patel's most frequent co-authors are Jeanny B. Aragon-Ching, MD, Esma A. Akin, MD and Karim Abdel Hafiz Arnaout, MD.

CMS Open Payments shows 524 general payments to Dr. Patel from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Daiichi Sankyo Inc. paid the most, $180,964.

Dr. Patel graduated from LSU Health Shreveport School of Medicine in 2007.

Dr. Patel is in network with 21 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.